
Sandy Feng
Vice Chair for Research · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
- Present
- Present
University of California (San Francisco) School of Medicine · University of Wisconsin Hospitals and Clinics
- 2021–2022

- 1982–1986
Harvard College
Research
Characteristics associated with liver graft failure: the concept of a donor risk index
American Journal of Transplantation · 2006 · First of 8 authors · Corresponding · 1,621 citations
Hepatology · 2014 · 773 citations
Expanded criteria donors for kidney transplantation
Review · American Journal of Transplantation · 2003 · 553 citations

32 papers · 19 as a resident

28 papers

22 papers

18 papers · 1 as a fellow
- JB
17 papers

15 papers

14 papers

14 papers
Grants
- 2025–2030
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.9M · University of California, San Francisco
- 2023–2024
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $270.7K · University of California, San Francisco
- 1996–2023
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $632.6K · University of California, San Francisco
- 2017–2022
Prospective Longitudinal Study of Iwith Screen Failures Secondary to Histopathology
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.3M · University of California, San Francisco
Clinical trials
- 2016–2019
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Principal investigator · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
- 2014–2019
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Principal investigator · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
- 2006–2017
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
- 2026–2031
Study chair · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)


